These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 24722449)

  • 41. C.E.R.A. administered once monthly corrects and maintains stable hemoglobin levels in chronic kidney disease patients not on dialysis: the observational study MICENAS II.
    Martínez-Castelao A; Cases A; Coll E; Bonal J; Galceran JM; Fort J; Moreso F; Torregrosa V; Guirado L; Ruiz P;
    Nefrologia; 2015; 35(1):80-6. PubMed ID: 25349927
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Darbepoetin alfa and chronic kidney disease.
    Hampl H; Kovesdy CP; Kalantar-Zadeh K
    N Engl J Med; 2010 Feb; 362(7):654; author reply 655. PubMed ID: 20187260
    [No Abstract]   [Full Text] [Related]  

  • 43. Recombinant Erythropoietin Provides Protection against Renal Fibrosis in Adenine-Induced Chronic Kidney Disease.
    Vázquez-Méndez E; Gutiérrez-Mercado Y; Mendieta-Condado E; Gálvez-Gastélum FJ; Esquivel-Solís H; Sánchez-Toscano Y; Morales-Martínez C; Canales-Aguirre AA; Márquez-Aguirre AL
    Mediators Inflamm; 2020; 2020():8937657. PubMed ID: 32184703
    [TBL] [Abstract][Full Text] [Related]  

  • 44. An ongoing study of anemia correction in chronic kidney disease.
    Pfeffer MA;
    N Engl J Med; 2007 Mar; 356(9):959-61. PubMed ID: 17329707
    [No Abstract]   [Full Text] [Related]  

  • 45. Efficacy and safety of once-monthly continuous erythropoietin receptor activator in patients with chronic renal anemia.
    Locatelli F; Mandolfo S; Menegato Adorati M; Villa G; Tarchini R; Pizzarelli F; Conte F; Guastoni C; Ricciardi B; Crotta A
    J Nephrol; 2013; 26(6):1114-21. PubMed ID: 24052462
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Emerging drugs for treatment of anemia of chronic kidney disease.
    Magwood JS; Lebby A; Chen B; Kessler S; Norris L; Bennett CL
    Expert Opin Emerg Drugs; 2013 Dec; 18(4):421-9. PubMed ID: 24033253
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Influence of continuous erythropoietin receptor activator on markers of cardiovascular risk in chronic kidney disease patients.
    Noce A; Dessì M; Durante O; Manca di Villahermosa S; Canale MP; Di Daniele N
    Int J Cardiol; 2013 Sep; 167(6):3070-2. PubMed ID: 23218579
    [No Abstract]   [Full Text] [Related]  

  • 48. Ergocalciferol decreases erythropoietin resistance in children with chronic kidney disease stage 5.
    Rianthavorn P; Boonyapapong P
    Pediatr Nephrol; 2013 Aug; 28(8):1261-6. PubMed ID: 23420502
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Treatment with erythropoiesis-stimulating agents in chronic kidney disease patients with cancer.
    Hazzan AD; Shah HH; Hong S; Sakhiya V; Wanchoo R; Fishbane S
    Kidney Int; 2014 Jul; 86(1):34-9. PubMed ID: 24402094
    [TBL] [Abstract][Full Text] [Related]  

  • 50. An immortalized cell line derived from renal erythropoietin-producing (REP) cells demonstrates their potential to transform into myofibroblasts.
    Sato K; Hirano I; Sekine H; Miyauchi K; Nakai T; Kato K; Ito S; Yamamoto M; Suzuki N
    Sci Rep; 2019 Aug; 9(1):11254. PubMed ID: 31375751
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Treatment of renal anaemia with erythropoiesis-stimulating agents in predialysis chronic kidney disease patients: Haemoglobin profile during the 6 months before initiation of dialysis.
    Kawahara K; Minakuchi J; Yokota N; Suekane H; Tsuchida K; Kawashima S
    Nephrology (Carlton); 2015 Dec; 20 Suppl 4():29-32. PubMed ID: 26456375
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Neutrophil gelatinase-associated lipocalin (NGAL) in chronic cardiorenal failure is correlated with endogenous erythropoietin levels and decreases in response to low-dose erythropoietin treatment.
    Emans ME; Braam B; Diepenbroek A; van der Putten K; Cramer MJ; Wielders JP; Swinkels DW; Doevendans PA; Gaillard CA
    Kidney Blood Press Res; 2012; 36(1):344-54. PubMed ID: 23235391
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Current pathogenetic concepts on the anemia of chronic renal insufficiency. Study of the behavior of the plasma erythropoietin in 28 cases of chronic kidney disease].
    PILIEGO N
    Rass Fisiopatol Clin Ter; 1962; 34():319-37. PubMed ID: 13943587
    [No Abstract]   [Full Text] [Related]  

  • 54. Management of anemia using erythropoiesis-stimulating agents.
    Giaquinta D
    Manag Care Interface; 2007 Jun; 20(6):24-5. PubMed ID: 17708079
    [No Abstract]   [Full Text] [Related]  

  • 55. Effect of Zinc Acetate Dihydrate (NobelzinR) Treatment on Anemia and Taste Disorders in Patients with Chronic Kidney Disease with Hypozincemia.
    Sato D; Gohda T; Kihara M; Kanaguchi Y; Kobayashi T; Mano S; Sasaki Y; Nohara N; Murakoshi M; Nakata J; Suzuki H; Ueda S; Horikoshi S; Suzuki Y
    Acta Med Okayama; 2018 Oct; 72(5):535-538. PubMed ID: 30369613
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pathophysiology of anemia in chronic kidney diseases: A review.
    Zadrazil J; Horak P
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2015 Jun; 159(2):197-202. PubMed ID: 24401900
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Induction of erythropoietin gene expression in epithelial cells by chemicals identified in GATA inhibitor screenings.
    Kaneko H; Katoh T; Hirano I; Hasegawa A; Tsujita T; Yamamoto M; Shimizu R
    Genes Cells; 2017 Nov; 22(11):939-952. PubMed ID: 29044949
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Role of ACE and IL-1β Gene Polymorphisms in Erythropoeitin Hyporesponsive Patients with Chronic Kidney Disease with Anemia.
    Nand N; Deshmukh AR; Joshi S; Sachdeva MP; Sakthivel
    J Assoc Physicians India; 2017 Feb; 65(2):32-36. PubMed ID: 28457029
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Erythropoietin Levels in Elderly Patients with Anemia of Unknown Etiology.
    Gowanlock Z; Sriram S; Martin A; Xenocostas A; Lazo-Langner A
    PLoS One; 2016; 11(6):e0157279. PubMed ID: 27310832
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A Placebo-Controlled, Randomized Trial of Enarodustat in Patients with Chronic Kidney Disease Followed by Long-Term Trial.
    Akizawa T; Nangaku M; Yamaguchi T; Arai M; Koretomo R; Matsui A; Hirakata H
    Am J Nephrol; 2019; 49(2):165-174. PubMed ID: 30699415
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.